Benzinga’s Top Ratings Upgrades, Downgrades For July 6, 2023
Upgrades According to RBC Capital, the prior rating for Repligen Corp (NASDAQ:RGEN) was changed from Sector Perform to…
Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is ‘Leader To Clinic In RNA Editing’
Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and
4D Molecular Poised For Success: FDA Discussion And Solid Position In Competitive Genetic Medicine Space, Says Analyst
Chardan Research analyst Geulah Livshits initiated coverage on 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) with a Buy rating and
Benzinga’s Top Ratings Upgrades, Downgrades For July 5, 2023
Upgrades According to Wedbush, the prior rating for Pegasystems Inc (NASDAQ:PEGA) was changed from Neutral to Outperform. For…
Benzinga’s Top Ratings Upgrades, Downgrades For July 3, 2023
Upgrades For Lazard Ltd (NYSE:LAZ), Wolfe Research upgraded the previous rating of Underperform to Peer Perform. Lazard earned…
Donnelley Financial Solutions’ Competitive Advantage To Widen With Enhanced Offerings: Analyst
Needham analyst Kyle Peterson initiated coverage on Donnelley Financial Solutions, Inc. (NYSE: DFIN) with a Buy rating and
Safehold At An Attractive Entry Point Amid Rising Interest Rates, Says Analyst
RBC Capital Markets analyst Kenneth S.
Benzinga’s Top Ratings Upgrades, Downgrades For June 30, 2023
Upgrades For Bright Health Group Inc (NYSE:BHG), Nephron Research upgraded the previous rating of Hold to Buy. In…
Benzinga’s Top Ratings Upgrades, Downgrades For June 29, 2023
Upgrades For OPKO Health Inc (NASDAQ:OPK), Barrington Research upgraded the previous rating of Market Perform to Outperform. For…
Extreme Networks Offers Attractive Valuation And Strong Growth Potential, Affirms Oppenheimer Analyst
Oppenheimer analyst Timothy Horan initiated coverage on shares of Extreme Networks, Inc. (NASDAQ: EXTR), with a